Page last updated: 2024-08-18

dimethyldioctadecylammonium and HIV Coinfection

dimethyldioctadecylammonium has been researched along with HIV Coinfection in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersen, P; Andreasen, LV; Bang, P; Fomsgaard, A; Gram, G; Karlsson, I; Kromann, I; Schou, C; Tang, S1

Other Studies

1 other study(ies) available for dimethyldioctadecylammonium and HIV Coinfection

ArticleYear
Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01.
    Vaccine, 2011, Sep-16, Volume: 29, Issue:40

    Topics: Adjuvants, Immunologic; AIDS Vaccines; Amino Acid Sequence; Animals; CD4-Positive T-Lymphocytes; Dogs; Drug Evaluation, Preclinical; Enzyme-Linked Immunospot Assay; Epitopes, T-Lymphocyte; Female; Glycolipids; HIV Infections; HIV-1; HLA-A2 Antigen; Immunity, Cellular; Immunization; Male; Mice; Mice, Knockout; Molecular Sequence Data; Peptides; Quaternary Ammonium Compounds; Swine; Swine, Miniature; T-Lymphocytes, Cytotoxic; Toxicity Tests

2011